| paclitaxel / Generic mfg. |
NCT00003334: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract |
|
|
| Completed | 2 | | US | paclitaxel, pegylated liposomal doxorubicin hydrochloride | NYU Langone Health, National Cancer Institute (NCI) | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma | 12/01 | | | |
NCT00003054: Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus |
|
|
| Terminated | 2 | | US, Canada | paclitaxel | Gynecologic Oncology Group, National Cancer Institute (NCI) | Sarcoma | 07/02 | | | |
NCT00003624: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer |
|
|
| Terminated | 2 | | US | amifostine trihydrate, cisplatin, paclitaxel | Gynecologic Oncology Group, National Cancer Institute (NCI) | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Sarcoma | 01/04 | | | |
NCT00020449: Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma |
|
|
| Completed | 2 | | US | recombinant interleukin-12, paclitaxel, pegylated liposomal doxorubicin hydrochloride | National Cancer Institute (NCI) | Sarcoma | | 05/04 | | |
NCT00505492: Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy |
|
|
| Terminated | 2 | 4 | US | Carboplatin, paraplatin, Cisplatin, Platinol-AQ, Platinol, CDDP, Paclitaxel, Taxol | M.D. Anderson Cancer Center | Uterine Neoplasms | 02/06 | 12/10 | | |
NCT00003008: Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma |
|
|
| Completed | 2 | 33 | US | indinavir sulfate, nelfinavir mesylate, paclitaxel, ritonavir, saquinavir mesylate | Eastern Cooperative Oncology Group, National Cancer Institute (NCI), AIDS Associated Malignancies Clinical Trials Consortium | Sarcoma | 06/06 | | | |
NCT00217607: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery |
|
|
| Completed | 2 | 30 | Europe | paclitaxel | UNICANCER | Sarcoma | 04/08 | 01/12 | | |
NCT00687687: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma |
|
|
| Completed | 2 | 22 | US | paclitaxel, carboplatin, BSI-201 (Iniparib), SAR204550 | Sanofi, Gynecologic Oncology Group | Uterine Carcinosarcoma | 03/10 | 12/11 | | |
NCT00059787: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma |
|
|
| Completed | 2 | 56 | US | paclitaxel, Anzatax, Asotax, TAX, Taxol, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, erlotinib, CP-358,774, OSI-774 | National Cancer Institute (NCI) | Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer | 05/10 | 05/10 | | |
NCT00112489: Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer |
|
|
| Completed | 2 | 55 | Japan, US | carboplatin, paclitaxel | Gynecologic Oncology Group, National Cancer Institute (NCI) | Sarcoma | 07/10 | | | |
NCT00502203: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus |
|
|
| Completed | 2 | 23 | US | Carboplatin, Paraplatin, Paclitaxel, Taxol | M.D. Anderson Cancer Center | Mixed Tumor, Mullerian | 11/10 | 11/10 | | |
NCT00511992: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer |
|
|
| Completed | 2 | 20 | US | Avastin, Bevacizumab, Paclitaxel, Cisplatin | University of Oklahoma, Genentech, Inc. | Advanced Ovarian Carcinoma, Primary Peritoneal Carcinoma, Ovarian Carcinosarcoma | 08/15 | 08/15 | | |
